NCT05406947View on ClinicalTrials.gov

Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children

Not yet recruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Medulloblastoma, Childhood
Interventions
OTHER

Prospective observational study, no intervention

Prospective observational study, no intervention

All Listed Sponsors
collaborator

Beijing Neurosurgical Institute

OTHER

collaborator

Beijing Children's Hospital

OTHER

collaborator

Beijing Shijitan Hospital, Capital Medical University

OTHER

collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

Peking University Third Hospital

OTHER

lead

Beijing Tiantan Hospital

OTHER

NCT05406947 - Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children | Biotech Hunter | Biotech Hunter